From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network

The Journal of Prevention of Alzheimer's Disease · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles